Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-25 @ 1:33 AM
NCT ID: NCT03903094
Eligibility Criteria: Inclusion Criteria: * Have at least one dispensing of any medication between January 22, 2016 and December 31, 2016. Inclusion Criteria for Korea: * Have at least one dispensing of any medication between January 1st, 2016 and December 31, 2016. * Participant was diagnosed with OAB (ICD-10 N32.8, N31.0, N31.1, N31.2, N31.8, N31.9, N32.9, N39.8 and N39.40) at index date. * Participant did not have dispensing record of an OAB medication during the washout period (6 months prior to the index date). Exclusion Criteria: * Participants who do not have a complete year of data availability in the database prior to index date. * Have record of hospitalization on the index date. Exclusion Criteria for Korea: * Participant was hospitalized on the index date. * Participant did not have an active insurance status during the washout period or on the index date. * Participant received onabotulinumtoxin A and/or surgical intervention as part of the OAB treatment during the washout period. * Participant was diagnosed with stress incontinence (ICD-10 N39.3 or equivalent) or had dispensing record of medication for stress incontinence (duloxetine) during the washout period. * Participant was diagnosed with urinary tract infection (ICD-10 N30.0 and N39.0 or equivalent) during the washout period or on the index date.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 65 Years
Study: NCT03903094
Study Brief:
Protocol Section: NCT03903094